News & Updates

Show Multimedia Only

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

01 May 2025 by

In the management of diabetes, users of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have a lower risk of all-cause dementia compared with users of other glucose-lowering medications, according to a systematic review and meta-analysis.

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

01 May 2025

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

01 May 2025

COVID-19 pandemic and pandemic-related events do not appear to have resulted in cognitive decline in middle-aged women, according to a study.

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

01 May 2025

Self-perceived stress tied to higher stroke risk in young women

01 May 2025 by

A recent study found that self-perceived stress may increase the risk of early-onset cryptogenic ischaemic stroke (CIS) in young adults, particularly women.

Self-perceived stress tied to higher stroke risk in young women

01 May 2025

Long-term D2 blockade not to blame for relapse in schizophrenia

29 Apr 2025

Continuous dopamine D2 receptor blockade does not appear to increase the risk of breakthrough psychosis in patients with first-episode schizophrenia, as shown in a study.

Long-term D2 blockade not to blame for relapse in schizophrenia

29 Apr 2025

Inebilizumab shows benefit in patients with gMG

29 Apr 2025 by

Treatment with inebilizumab significantly improved generalized myasthenia gravis (gMG) symptoms, as shown by a greater reduction in MG-Activities of Daily Living (MG-ADL) scores, among patients who were acetylcholine receptor antibody-positive (AChR-Ab+) or muscle-specific kinase antibody-positive (MuSK-Ab+), according to the phase III MINT* trial presented at AAN 2025.

Inebilizumab shows benefit in patients with gMG

29 Apr 2025

Certain young stroke survivors can’t get back to work despite recovery

24 Apr 2025 by

Even as most young people survive ischaemic stroke and achieve functional recovery, only six out of 10 are able to resume work, as shown in a study from Singapore.

Certain young stroke survivors can’t get back to work despite recovery

24 Apr 2025

AI-driven, wrist-worn stimulation device reduces essential tremors

22 Apr 2025 by

A wrist-worn wearable that harnesses artificial intelligence (AI) for noninvasive modulation of the nervous system appears beneficial in patients with essential tremor, enabling them to regain greater control over their upper limb movements for everyday activities.